Novel Amidine Derivative K1586 Sensitizes Colorectal Cancer Cells to Ionizing Radiation by Inducing Chk1 Instability
Open Access
- 16 April 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (8) , 4396
Abstract
Checkpoint kinase 1 (Chk1) is a key mediator of the DNA damage response that regulates cell cycle progression, DNA damage repair, and DNA replication. Small-molecule Chk1 inhibitors sensitize cancer cells to genotoxic agents and have shown preclinical activity as single agents in cancers characterized by high levels of replication stress. However, the underlying genetic determinants of Chk1-inhibitor sensitivity remain unclear. Although treatment options for advanced colorectal cancer are limited, radiotherapy is effective. Here, we report that exposure to a novel amidine derivative, K1586, leads to an initial reduction in the proliferative potential of colorectal cancer cells. Cell cycle analysis revealed that the length of the G2/M phase increased with K1586 exposure as a result of Chk1 instability. Exposure to K1586 enhanced the degradation of Chk1 in a time- and dose-dependent manner, increasing replication stress and sensitizing colorectal cancer cells to radiation. Taken together, the results suggest that a novel amidine derivative may have potential as a radiotherapy-sensitization agent that targets Chk1.Keywords
Funding Information
- The Ministry of Science, ICT and Future Planning, Republic of Korea (50531-2023)
This publication has 38 references indexed in Scilit:
- New amidine-benzenesulfonamides as iNOS inhibitors for the therapy of the triple negative breast cancerEuropean Journal of Medicinal Chemistry, 2023
- CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentiniScience, 2021
- ATR/CHK1 inhibitors and cancer therapyRadiotherapy and Oncology, 2018
- Downregulation of cell division cycle 25 homolog C reduces the radiosensitivity and proliferation activity of esophageal squamous cell carcinomaGene, 2016
- Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitorInvestigational New Drugs, 2013
- Synthesis of amidine and bis amidine derivatives and their evaluation for anti-inflammatory and anticancer activityEuropean Journal of Medicinal Chemistry, 2013
- Synthesis, anticancer, and anti-inflammatory activity evaluation of methanesulfonamide and amidine derivatives of 3,4-diaryl-2-imino-4-thiazolinesMolecular Diversity, 2009
- Structure-specific recognition of quadruplex DNA by organic cations: Influence of shape, substituents and chargeBiophysical Chemistry, 2007
- Genotoxic Stress Targets Human Chk1 for Degradation by the Ubiquitin-Proteasome PathwayMolecular Cell, 2005
- A thermodynamic and structural analysis of DNA minor-groove complex formation 1 1Edited by I. TinocoJournal of Molecular Biology, 2000